# BETAINE
> **ANDA210508** · Abbreviated New Drug Application (Generic) · Sponsor: ETON · Approved 2022-01-28
## Drug
- **FDA Application Number:** ANDA210508
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BETAINE
- **Generic name:** BETAINE ANHYDROUS
- **Active ingredients:** BETAINE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ETON
- **Manufacturer:** Eton Pharmaceuticals, Inc.
- **First approval:** 2022-01-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210508)
---
*AI Analytics · CC0 1.0*